MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics

Prostate Cancer and Prostatic Diseases
A GordanpourA Seth

Abstract

MicroRNAs (miRNAs) are effective regulators of gene expression that have a significant role in the pathogenesis of prostate and various other cancers. The high prevalence of aberrant miRNA expression in prostate cancer, and miRNAs' distinctive properties, give much hope that they can be used as biomarkers and next generation of molecular anticancer therapeutics. Herein, we review the literature on miRNA involvement in prostate cancer pathogenesis and the current understanding of their role as oncogenes, tumor suppressors and metastasis-regulators. We also review the latest research on miRNAs in prostate cancer preclinical studies and clinical trials, and highlight the advantages and challenges of possible miRNA-based therapies. The emerging information regarding the biology of miRNAs in prostate cancer is promising, and may lead to a role(s) for these molecules as diagnostic/prognostic markers and effective therapeutic tools for better molecularly targeted treatment of prostate cancer.

References

Jul 9, 2002·Genes & Development·Brenda J ReinhartDavid P Bartel
Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Dec 6, 2003·Science·Chang-Zheng ChenDavid P Bartel
Dec 31, 2003·Cell·Benjamin P LewisChristopher B Burge
Apr 5, 2005·Nature Genetics·Azra KrekNikolaus Rajewsky
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Oct 5, 2006·European Biophysics Journal : EBJ·Inge S ZuhornDick Hoekstra
May 31, 2007·Proceedings of the National Academy of Sciences of the United States of America·J Robin LytleJoan A Steitz
Jul 10, 2007·Cancer Research·Kati P PorkkaTapio Visakorpi
Dec 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jami McLaughlinOwen N Witte
Dec 26, 2007·Nucleic Acids Research·Doron BetelChris Sander
Jan 5, 2008·RNA·Shi-Lung LinShao-Yao Ying
Jan 15, 2008·Nature Cell Biology·Qihong HuangReuven Agami
Jan 15, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Alla MusiyenkoSailen Barik
Mar 28, 2008·RNA·Anja M DuursmaReuven Agami
May 24, 2008·Molecular Cell·Ulf Andersson ØromAnders H Lund
Jul 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Patrick S MitchellMuneesh Tewari
Aug 23, 2008·Cell Cycle·Susana GonzalezManuel Serrano
Oct 7, 2008·Biochemical and Biophysical Research Communications·Yasunori FujitaMasafumi Ito
Oct 10, 2008·Cell Cycle·María José BuenoMarcos Malumbres
Oct 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Daniel H KimJohn J Rossi
Oct 25, 2008·Cancer Gene Therapy·A W TongJ Nemunaitis
Oct 29, 2008·Genome Research·Robin C FriedmanDavid P Bartel
Nov 15, 2008·Science·Sooryanarayana VaramballyArul M Chinnaiyan
Jul 9, 2009·The Journal of Biological Chemistry·Michael R EpisPeter J Leedman
Sep 10, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Fumitaka TakeshitaTakahiro Ochiya
Sep 24, 2009·Cancer Research·Douglas R HurstDanny R Welch
Jan 21, 2010·Cell·Basel KhraiweshWolfgang Frank
Mar 17, 2010·The International Journal of Biochemistry & Cell Biology·Anita G Seto
Jun 24, 2010·Cancer Research·Jason F WigginsAndreas G Bader
Sep 3, 2010·Cancer Research·Andreas G BaderMatthew Winkler
Oct 5, 2010·Nature Reviews. Drug Discovery·Ramiro GarzonCarlo M Croce
Nov 3, 2010·Nucleic Acids Research·Ana Kozomara, Sam Griffiths-Jones
Nov 17, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fabio Petrocca, Judy Lieberman
Dec 15, 2010·Protein & Cell·Yong HuangXingjia Shen

❮ Previous
Next ❯

Citations

Aug 21, 2013·PloS One·D Rice HoneywellChristina L Addison
Nov 30, 2012·Advances in Bioinformatics·Mohammed Alshalalfa
Feb 28, 2014·Expert Opinion on Therapeutic Targets·Konstantinos MavridisAndreas Scorilas
Aug 26, 2014·Expert Review of Anticancer Therapy·Pedro Costa-PinheiroCarmen Jerónimo
Jan 23, 2016·Cellular Oncology (Dordrecht)·Sharanjot Saini
Jan 7, 2014·Journal of Zhejiang University. Science. B·Juliana FelgueirasMargarida Fardilha
Dec 20, 2015·PloS One·Jennifer S MyersQing-Xiang Amy Sang
Mar 13, 2013·International Journal of Molecular Sciences·Hong W H YuWilliam C S Cho
Jun 19, 2013·International Journal of Molecular Sciences·Marina RigauAndreas Doll
Jan 5, 2019·The Prostate·Mingfeng ZhaoBo Han
Feb 2, 2013·Molecular Biotechnology·Tasnima Khushnud, Shaker A Mousa
Mar 28, 2017·Journal of Clinical Urology·Niels Asger JakobsenRichard John Bryant
Apr 4, 2021·Pharmaceutics·Noemi Arrighetti, Giovanni Luca Beretta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Irene Casanova-SalasJose Antonio López-Guerrero
Pharmaceutical Research
Sharanjot SainiRajvir Dahiya
© 2022 Meta ULC. All rights reserved